Matinas BioPharma Holdings, Inc. (MTNB) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
MTNB Historical Performance
Short-Term Returns
MTNB Stock Price Trajectory (2014–2026)
As of May 8, 2026, Matinas BioPharma Holdings, Inc. (MTNB) trades at $0.65, representing a -7.7% return over the past year. The stock has delivered a -98.3% total return over five years (-56.0% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $199.50 on March 2, 2017. From this peak, MTNB has corrected -99.7%, currently trading 37% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ARQT (+50.8% 1Y), NKTR (+818.2% 1Y), and PRAX (+775.0% 1Y), MTNB has underperformed the peer group average. Compare MTNB vs ARQT →
MTNB Historical Price Data (2025–2026)
Showing 30 of 2,969 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 0.66 | 0.67 | 0.64 | 0.65 | 16K | -3.94% |
| 2026-05-06 | 0.66 | 0.70 | 0.66 | 0.68 | 44K | +1.40% |
| 2026-05-05 | 0.68 | 0.70 | 0.65 | 0.67 | 21K | +0.09% |
| 2026-05-04 | 0.70 | 0.70 | 0.67 | 0.67 | 17K | -4.15% |
| 2026-05-01 | 0.69 | 0.70 | 0.64 | 0.70 | 33K | +7.47% |
| 2026-04-30 | 0.63 | 0.67 | 0.58 | 0.65 | 56K | +4.89% |
| 2026-04-29 | 0.60 | 0.62 | 0.59 | 0.62 | 32K | +0.10% |
| 2026-04-28 | 0.60 | 0.61 | 0.60 | 0.62 | 6K | +1.56% |
| 2026-04-27 | 0.57 | 0.62 | 0.57 | 0.61 | 22K | 0.00% |
| 2026-04-24 | 0.62 | 0.62 | 0.60 | 0.61 | 22K | +0.66% |
| 2026-04-23 | 0.58 | 0.63 | 0.57 | 0.61 | 65K | +8.18% |
| 2026-04-22 | 0.56 | 0.57 | 0.56 | 0.56 | 19K | +1.84% |
| 2026-04-21 | 0.56 | 0.57 | 0.55 | 0.55 | 30K | +0.20% |
| 2026-04-20 | 0.49 | 0.56 | 0.49 | 0.55 | 79K | +9.80% |
| 2026-04-17 | 0.53 | 0.54 | 0.50 | 0.50 | 20K | -4.76% |
| 2026-04-16 | 0.53 | 0.53 | 0.49 | 0.53 | 37K | 0.00% |
| 2026-04-15 | 0.51 | 0.54 | 0.50 | 0.53 | 33K | -0.76% |
| 2026-04-14 | 0.49 | 0.53 | 0.49 | 0.53 | 114K | +5.17% |
| 2026-04-13 | 0.52 | 0.53 | 0.50 | 0.50 | 6K | +0.60% |
| 2026-04-10 | 0.54 | 0.54 | 0.50 | 0.50 | 15K | -0.97% |
| 2026-04-09 | 0.48 | 0.53 | 0.48 | 0.50 | 13K | +3.04% |
| 2026-04-08 | 0.50 | 0.52 | 0.48 | 0.49 | 20K | -2.49% |
| 2026-04-07 | 0.53 | 0.53 | 0.48 | 0.50 | 34K | -8.64% |
| 2026-04-06 | 0.51 | 0.55 | 0.48 | 0.55 | 15K | +0.64% |
| 2026-04-02 | 0.50 | 0.55 | 0.48 | 0.55 | 15K | -0.64% |
| 2026-04-01 | 0.55 | 0.55 | 0.50 | 0.55 | 21K | +10.00% |
| 2026-03-31 | 0.56 | 0.57 | 0.48 | 0.50 | 55K | -11.82% |
| 2026-03-30 | 0.58 | 0.60 | 0.57 | 0.57 | 10K | -3.56% |
| 2026-03-27 | 0.62 | 0.63 | 0.57 | 0.59 | 63K | -1.43% |
| 2026-03-26 | 0.61 | 0.61 | 0.59 | 0.60 | 16K | -3.10% |
See MTNB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MTNB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MTNB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMTNB — Frequently Asked Questions
Quick answers to the most common questions about buying MTNB stock.
How has MTNB stock performed recently?
MTNB declined -7.7% over the past year, below its 5-year annualized CAGR of -56.0%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is MTNB's all-time high price?
Matinas BioPharma Holdings, Inc. reached $199.50 on 2017-03-02. The 52-week high is $3.09. Current 1-year return of -7.7% places the stock further from historical peaks.
Where can I download MTNB historical price data?
This page provides MTNB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.